<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-14-06903</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0106631</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Human genetics</subject><subj-group><subject>Genetic association studies</subject></subj-group></subj-group><subj-group><subject>Genetics of disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Nephrology</subject><subj-group><subject>Chronic kidney disease</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>A Gene Variant in CERS2 Is Associated with Rate of Increase in Albuminuria in Patients with Diabetes from ONTARGET and TRANSCEND</article-title>
<alt-title alt-title-type="running-head">CERS2 and Increased Albuminuria</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shiffman</surname><given-names>Dov</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pare</surname><given-names>Guillaume</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oberbauer</surname><given-names>Rainer</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Louie</surname><given-names>Judy Z.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rowland</surname><given-names>Charles M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Devlin</surname><given-names>James J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mann</surname><given-names>Johannes F.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>McQueen</surname><given-names>Matthew J.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Celera, Alameda, CA, United States of America</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Nephrology, KH Elisabethinen, Linz, Austria and Department of Nephrology, Medical University of Vienna, Vienna, Austria</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Nephrology and Hypertension, Friedrich Alexander University, Erlangen, Germany</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Abe</surname><given-names>Hideharu</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Tokushima, Japan</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">dov.shiffman@celera.com</email></corresp>
<fn fn-type="conflict"><p>DS, JZL, CMR, and JJD are employees of Celera, a Quest Diagnostics company. DS, GP, JZL, CMR, JJD and MJM are named as inventors on the following patent application filed by Quest Diagnostics relating to the association of CERS2 variants with increased albuminuria “GENETIC POLYMORPHISMS ASSOCIATED WITH CHRONIC KIDNEY DISEASE, METHODS OF DETECTION AND USES THEREOF” Provisional applications serial no. 61/836,403 and serial no. 61/836,491). Boehringer Ingelheim has funded the ONTARGET and TRANSCEND studies. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: DS GP RO JJD JFM MJM. Performed the experiments: GP DS MJM. Analyzed the data: DS GP JJD JZL CMR. Contributed reagents/materials/analysis tools: GP JFM MJM. Wrote the paper: DS GP RO JJD JFM MJM.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>19</day><month>9</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>9</issue>
<elocation-id>e106631</elocation-id>
<history>
<date date-type="received"><day>19</day><month>2</month><year>2014</year></date>
<date date-type="accepted"><day>6</day><month>8</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Shiffman et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Although albuminuria and subsequent advanced stage chronic kidney disease are common among patients with diabetes, the rate of increase in albuminuria varies among patients. Since genetic variants associated with estimated glomerular filtration rate (eGFR) were identified in cross sectional studies, we asked whether these variants were also associated with rate of increase in albuminuria among patients with diabetes from ONTARGET and TRANSCEND—randomized controlled trials of ramipril, telmisartan, both, or placebo. For 16 genetic variants associated with eGFR at a genome-wide level, we evaluated the association with annual rate of increase in albuminuria estimated from urine albumin:creatinine ratio (uACR). One of the variants (rs267734) was associated with rate of increase in albuminuria. The annual rate of increase in albuminuria among risk homozygotes (69% of the study population) was 11.3% (95%CI; 7.5% to 15.3%), compared with 5.0% (95%CI; 3.3% to 6.8%) for heterozygotes (27% of the population), and 1.7% (95%CI; −1.7% to 5.3%) for non-risk homozygotes (4% of the population); P = 0.0015 for the difference between annual rates in the three genotype groups. These estimates were adjusted for age, sex, ethnicity, and principal component of genetic heterogeneity. Among patients without albuminuria at baseline (uACR&lt;30 mg/g), each risk allele was associated with 50% increased risk of incident albuminuria (OR = 1.50; 95%CI 1.15 to 1.95; P = 0.003) after further adjustment for traditional risk factors including baseline uACR and eGFR. The rs267734 variant is in almost perfect linkage-disequilibrium (r<sup>2</sup> = 0.94) with rs267738, a single nucleotide polymorphism encoding a glutamic acid to alanine change at position 115 of the ceramide synthase 2 (CERS2) encoded protein. However, it is unknown whether CERS2 function influences albuminuria. In conclusion, we found that rs267734 in CERS2 is associated with rate of increase in albuminuria among patients with diabetes and elevated risk of cardiovascular disease.</p>
</abstract>
<funding-group><funding-statement>The research leading to these results has received funding from the European Community's Seventh Framework Programme under the grant agreement n ° 241544. Funding for ONTARGET and TRANSCEND Studies: Boehringer Ingelheim. The funders had no role in study design, data collection and analysis, decision to publish. Co-authors DS, JZL, CMR, and JJD are employed by Celera. Celera provided support in the form of salaries for authors DS, JZL, CMR, and JJD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.</funding-statement></funding-group><counts><page-count count="10"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Chronic kidney disease (CKD) is a common complication of type 2 diabetes and is becoming an increased burden on the medical system. Half of all patients with end stage renal disease starting dialysis suffer from type 2 diabetes mellitus <xref ref-type="bibr" rid="pone.0106631-US1">[1]</xref>. In patients with diabetes, CKD frequently manifests as albuminuria prior to measurable decline in kidney function as assessed by estimated glomerular filtration rates (eGFR). It has been estimated that about 30% of patients with type 2 diabetes become either micro- or macro-albuminuric within 10 years of diagnosis <xref ref-type="bibr" rid="pone.0106631-Adler1">[2]</xref>. However, the rate of CKD progression in patients with diabetes is modest: on average only 2% to 5% become micro-albuminuric each year <xref ref-type="bibr" rid="pone.0106631-Adler1">[2]</xref>, <xref ref-type="bibr" rid="pone.0106631-Mann1">[3]</xref>. Identification of patients with diabetes who are at high risk for CKD progression could help focus medical resources on preventing their progression to end-stage renal disease. Several risk factors for CKD progression including systolic blood pressure, urinary albumin, plasma creatinine, and ethnicity were identified in UKPDS, an observational study of about 5,000 patients with type 2 diabetes <xref ref-type="bibr" rid="pone.0106631-Retnakaran1">[4]</xref>.</p>
<p>Genetic analysis of kidney disease has largely focused on cross-sectional and case-control studies. A genome-wide meta-analysis investigated the association between genetic variants and eGFR in about 90,000 individuals from mostly population-based studies. This cross-sectional analysis identified 16 single nucleotide polymorphisms (SNPs) that were associated with eGFR at a genome-wide significance level (P&lt;5×10<sup>−8</sup>) <xref ref-type="bibr" rid="pone.0106631-Kttgen1">[5]</xref>. The association of these 16 SNPs with incident CKD was investigated in about 26,000 individuals in eight population-based studies <xref ref-type="bibr" rid="pone.0106631-Bger1">[6]</xref>. Only 6 of these loci were associated with incident CKD after adjustment for baseline eGFR. However, these genetic analyses were conducted in population based studies that were not enriched for patients with diabetes. More recently, these 16 SNPs were investigated in a prospective study of about 3000 patients with type 2 diabetes <xref ref-type="bibr" rid="pone.0106631-Deshmukh1">[7]</xref>. After correction for multiple testing, none of these SNPs was associated with incident CKD.</p>
<p>The association of these 16 SNPs with albuminuria was investigated in a large cross-sectional study of individuals with European ancestry <xref ref-type="bibr" rid="pone.0106631-Ellis1">[8]</xref>. In this study the minor allele of a SNP in the SHROOM3 gene was associated with low albuminuria (i.e., better kidney function), a puzzling finding since this same allele is associated with low levels of eGFR.</p>
<p>In this current study we investigated 16 SNPs, that were reported to be associated with eGFR, among patients with type 2 diabetes from European and non-European ancestry enrolled in two randomized controlled trials of ramipril, telmisartan, both, or placebo (ONTARGET and TRANSCEND). We asked whether these 16 SNPs are also associated with early kidney disease measured by accelerated increase in albuminuria.</p>
</sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Study design</title>
<p>This substudy of ONTARGET (ClinicalTrials.gov Identifier: NCT00153101) and TRANSCEND (ClinicalTrials.gov Identifier: NCT00153101) investigated whether 16 SNPs that were previously shown to be associated with eGFR in a cross sectional analysis are also associated with annual rate of increase in albuminuria among patients with diabetes. The ONTARGET and TRANSCEND studies were previously described <xref ref-type="bibr" rid="pone.0106631-Teo1">[9]</xref>–<xref ref-type="bibr" rid="pone.0106631-Yusuf2">[11]</xref>. Briefly, these studies included patients 55 years and older with atherosclerotic vascular disease or diabetes and retinopathy, left ventricular hypertrophy, micro- or macro-albuminuria, or a history of cardiac or vascular disease. Patients in ONTARGET were randomized to ramipril (10 mg/day), telmisartan (80 mg/day), or both. Patients intolerant to angiotensin converting enzyme inhibitors were included in the TRANSCEND study and were randomized to telmisartan (80 mg/day) or placebo. Patients in both studies were followed up for 56 months. This substudy included patients who had prevalent or incident diabetes and was drawn from ∼10,000 patients who provided blood samples for DNA analysis. Reasonable efforts were made to collect blood samples for DNA from all ONTARGET/TRANSCEND patients. However, in some countries funding constraints and other difficulties prevented transfer of samples to the core laboratory in Hamilton, and some individual centers or investigators declined to participate. Additionally, blood samples from ∼2000 patients enrolled in China were not included because authorities in Beijing would not allow export of DNA. Diabetes was defined as fasting glucose&gt;125 mg/dl, 2 hour oral glucose tolerance test&gt;199 mg/dl, use of antidiabetic medication, or new diabetes reported by the physician. Albuminuria was estimated from measurement of uACR from a first morning spot urine sample and eGFR was calculated from serum creatinine measurement using the Modification of Diet in Renal Disease (MDRD) formula. Genotyping was conducted using the Cardio-Metabo Chip from Illumina (San Diego CA) which interrogates about 200,000 SNPs, mostly from regions previously shown to be associated with risk of cardiovascular disease, type 2 diabetes, and related quantitative traits <xref ref-type="bibr" rid="pone.0106631-Voight1">[12]</xref>. Quality control was performed according to Fellay et al. <xref ref-type="bibr" rid="pone.0106631-Fellay1">[13]</xref> Briefly, we excluded samples that had &lt;99% call rate. The call rate was calculated based on a total of 189,632 SNPs (96.4% of all Metabochip SNPs) after exclusion of markers that did not achieve&gt;99% call frequency (n = 6,281), markers that had poor signal clustering <xref ref-type="bibr" rid="pone.0106631-Fellay1">[13]</xref> (n = 783), or markers that had low signal intensity (n = 29). Genotyping reproducibility for 34 samples that were run in duplicates was&gt;99.99%. Genotypes for SNPs in this study that were not present on the Cardio-Metabo Chip were assessed by allele-specific polymerase chain reaction (PCR) <xref ref-type="bibr" rid="pone.0106631-Shiffman1">[14]</xref>. All the SNPs in this study did not deviate from Hardy-Weinberg equilibrium expectations (P&gt;10<sup>−6</sup>). This substudy of ONTARGET and TRANSCEND was approved by the Hamilton Health Sciences and McMaster University Research Ethics Board. All participants provided a written informed consent.</p>
</sec><sec id="s2b">
<title>Statistical analysis</title>
<p>Participant characteristics at baseline were described by counts and percent, by medians and inter-quartile ratios, or by means and standard deviations (<xref ref-type="table" rid="pone-0106631-t001">Table 1</xref>). Deviation from Hardy-Weinberg equilibrium expectations was assessed by an exact test for bi-allelic markers.</p>
<table-wrap id="pone-0106631-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106631.t001</object-id><label>Table 1</label><caption>
<title>Baseline characteristics.</title>
</caption><alternatives><graphic id="pone-0106631-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0106631.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">Patients in Genetic Analysis</td>
<td colspan="2" align="left" rowspan="1">All Patients</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Baseline Characteristic</td>
<td align="left" rowspan="1" colspan="1">ONTARGET (n = 3128)</td>
<td align="left" rowspan="1" colspan="1">TRANSCEND (n = 595)</td>
<td align="left" rowspan="1" colspan="1">ONTARGET (n = 13094)</td>
<td align="left" rowspan="1" colspan="1">TRANSCEND (n = 3255)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Age, years, mean (SD)</td>
<td align="left" rowspan="1" colspan="1">66.6 (7.2)</td>
<td align="left" rowspan="1" colspan="1">67.8 (7.5)</td>
<td align="left" rowspan="1" colspan="1">66.1 (6.9)</td>
<td align="left" rowspan="1" colspan="1">66.8 (7.2)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male, n (%)</td>
<td align="left" rowspan="1" colspan="1">2197 (70.2)</td>
<td align="left" rowspan="1" colspan="1">309 (51.9)</td>
<td align="left" rowspan="1" colspan="1">9205 (70.3)</td>
<td align="left" rowspan="1" colspan="1">1772 (54.4)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Systolic blood pressure, mmHg, mean (SD)</td>
<td align="left" rowspan="1" colspan="1">142.5 (17.4)</td>
<td align="left" rowspan="1" colspan="1">141.1 (17.4)</td>
<td align="left" rowspan="1" colspan="1">143.2 (17.1)</td>
<td align="left" rowspan="1" colspan="1">142.0 (16.6)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diastolic blood pressure, mmHg, mean (SD)</td>
<td align="left" rowspan="1" colspan="1">81.0 (10.3)</td>
<td align="left" rowspan="1" colspan="1">80.6 (9.9)</td>
<td align="left" rowspan="1" colspan="1">82.1 (10.3)</td>
<td align="left" rowspan="1" colspan="1">81.9 (10.2)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td>
<td align="left" rowspan="1" colspan="1">1900 (60.7)</td>
<td align="left" rowspan="1" colspan="1">348 (58.5)</td>
<td align="left" rowspan="1" colspan="1">8279 (63.3)</td>
<td align="left" rowspan="1" colspan="1">1982 (61.0)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">uACR, mg/g, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">6.2 (2.7 to 29.4)</td>
<td align="left" rowspan="1" colspan="1">4.7 (2.6 to 12.7)</td>
<td align="left" rowspan="1" colspan="1">6.5 (2.7 to 30.5)</td>
<td align="left" rowspan="1" colspan="1">5.3 (2.5 to 14.5)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">&lt;30 mg/g, n (%)</td>
<td align="left" rowspan="1" colspan="1">2241 (71.6)</td>
<td align="left" rowspan="1" colspan="1">500 (84.0)</td>
<td align="left" rowspan="1" colspan="1">8957 (68.4)</td>
<td align="left" rowspan="1" colspan="1">2525 (77.6)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">30 to 300 mg/g, n (%)</td>
<td align="left" rowspan="1" colspan="1">539 (17.2)</td>
<td align="left" rowspan="1" colspan="1">56 (9.4)</td>
<td align="left" rowspan="1" colspan="1">2196 (16.8)</td>
<td align="left" rowspan="1" colspan="1">387 (11.9)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">&gt;300 mg/g, n (%)</td>
<td align="left" rowspan="1" colspan="1">201 (6.4)</td>
<td align="left" rowspan="1" colspan="1">6 (1.0)</td>
<td align="left" rowspan="1" colspan="1">813 (6.2)</td>
<td align="left" rowspan="1" colspan="1">61 (1.9)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Missing baseline data, n (%)</td>
<td align="left" rowspan="1" colspan="1">147 (4.7)</td>
<td align="left" rowspan="1" colspan="1">33 (5.5)</td>
<td align="left" rowspan="1" colspan="1">1128 (8.6)</td>
<td align="left" rowspan="1" colspan="1">282 (8.7)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">eGFR, ml/min/1.73 m2, mean (SD)</td>
<td align="left" rowspan="1" colspan="1">74.0 (21.0)</td>
<td align="left" rowspan="1" colspan="1">71.5 (20.5)</td>
<td align="left" rowspan="1" colspan="1">73.3 (20.7)</td>
<td align="left" rowspan="1" colspan="1">71.7 (20.1)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ever smoked, n (%)</td>
<td align="left" rowspan="1" colspan="1">2071 (66.2)</td>
<td align="left" rowspan="1" colspan="1">327 (55.0)</td>
<td align="left" rowspan="1" colspan="1">8160 (62.4)</td>
<td align="left" rowspan="1" colspan="1">1599 (49.3)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Self-reported ethnicity</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">European, n (%)</td>
<td align="left" rowspan="1" colspan="1">2377 (76.0)</td>
<td align="left" rowspan="1" colspan="1">430 (72.3)</td>
<td align="left" rowspan="1" colspan="1">9146 (69.9)</td>
<td align="left" rowspan="1" colspan="1">1879 (57.7)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian, n (%)</td>
<td align="left" rowspan="1" colspan="1">419 (13.4)</td>
<td align="left" rowspan="1" colspan="1">109 (18.3)</td>
<td align="left" rowspan="1" colspan="1">1927 (14.7)</td>
<td align="left" rowspan="1" colspan="1">758 (23.3)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Native Latin, n (%)</td>
<td align="left" rowspan="1" colspan="1">172 (5.5)</td>
<td align="left" rowspan="1" colspan="1">35 (5.9)</td>
<td align="left" rowspan="1" colspan="1">1233 (9.4)</td>
<td align="left" rowspan="1" colspan="1">444 (13.6)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">African, n (%)</td>
<td align="left" rowspan="1" colspan="1">160 (5.1)</td>
<td align="left" rowspan="1" colspan="1">21 (3.5)</td>
<td align="left" rowspan="1" colspan="1">424 (3.2)</td>
<td align="left" rowspan="1" colspan="1">70 (2.2)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Treatment group</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Placebo, n (%)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">299 (50.3)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">1629 (50.0)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ramipril, n (%)</td>
<td align="left" rowspan="1" colspan="1">1031 (33.0)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">4346 (33.2)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Telmisartan, n (%)</td>
<td align="left" rowspan="1" colspan="1">1067 (34.1)</td>
<td align="left" rowspan="1" colspan="1">296 (49.7)</td>
<td align="left" rowspan="1" colspan="1">4463 (34.1)</td>
<td align="left" rowspan="1" colspan="1">1626 (50.0)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ramipril and Telmisartan, n (%)</td>
<td align="left" rowspan="1" colspan="1">1030 (32.9)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">4285 (32.7)</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diabetes</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Incident, n (%)</td>
<td align="left" rowspan="1" colspan="1">649 (20.7)</td>
<td align="left" rowspan="1" colspan="1">154 (25.9)</td>
<td align="left" rowspan="1" colspan="1">2524 (19.3)</td>
<td align="left" rowspan="1" colspan="1">790 (24.3)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Prevalent, n (%)</td>
<td align="left" rowspan="1" colspan="1">2479 (79.3)</td>
<td align="left" rowspan="1" colspan="1">441 (74.1)</td>
<td align="left" rowspan="1" colspan="1">10570 (80.7)</td>
<td align="left" rowspan="1" colspan="1">2465 (75.7)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>SD, standard deviation. IQR, inter-quartile range. NA, not applicable.</p></fn></table-wrap-foot></table-wrap>
<p>For regression models that included SNPs, genotypes were coded as 0, 1, or 2 pre-specified risk alleles using an additive model. Because genetic risk factors can have different magnitude in different ethnic groups, we investigated SNPs in ethnic groups separately. Specifically, SNPs were investigated in 4 ethnic groups: self-reported Europeans, Asians (including self-reported Chinese, Japanese, South Asians, other Asians, and Malaysians), Africans (self-reported Black African and Colored African) and self-reported Native Latin. Self-reported Arabs or Persians (n = 9) and others (n = 118) were excluded from the analysis. EIGENSTRAT software <xref ref-type="bibr" rid="pone.0106631-Price1">[15]</xref> was used to calculate the principal components of genetic variability separately in each of the 4 ethnic groups. The principal components were calculated using genotypes from about 50,000 autosomal SNPs that were selected for each ethnic group from the Cardio-Metabo Chip, such that they were not in linkage disequilibrium with one another (r<sup>2</sup>&lt;0.2 in each ethnic group). Patients who were identical by descent (n = 11), or those for whom the first 3 principal components of genetic variability clearly indicated that their genetic ancestry differed from their self-reported ethnicity (n = 34) were excluded. In the basic model, regression models adjusted for age, sex, and to adjust for population structure, the 10 largest ethnic-specific principal components. Results from the 4 ethnic groups were combined using random effects models <xref ref-type="bibr" rid="pone.0106631-DerSimonian1">[16]</xref>. The dependent variables eGFR and uACR were natural-log transformed. A fully adjusted model also included baseline hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg), baseline eGFR, baseline uACR, smoking status, study (ONTARGET or TRANSCEND), and treatment group. Associations between SNPs and baseline albuminuria or eGFR were assessed using linear regression models. Associations between SNPs and annual rate of change in albuminuria or change in eGFR were assessed using linear mixed models allowing for patient specific random intercepts and slopes. The fixed effects included in the linear mixed models were, visit (0, 2, or 5 years), SNP (number of risk alleles), an interaction term between visit and SNP and remaining basic model variables. The general model in equation form is:</p>
<p><disp-formula id="pone.0106631.e001"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pone.0106631.e001" xlink:type="simple"/></disp-formula>where:</p>
<p><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e002" xlink:type="simple"/></inline-formula> is the observed measure of urine albumin at Year j for subject i, i = 1, …, M subjects; j = 1, …, n<sub>i</sub> visits.</p>
<p><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e003" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e004" xlink:type="simple"/></inline-formula>are combined to estimate mean genotype specific population intercepts.</p>
<p><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e005" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e006" xlink:type="simple"/></inline-formula>are combined to estimate mean genotype specific population slopes.</p>
<p><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e007" xlink:type="simple"/></inline-formula> estimates the deviation from the population intercept for subject i and are assumed independent and Gaussian with mean 0 and variance <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e008" xlink:type="simple"/></inline-formula>.</p>
<p><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e009" xlink:type="simple"/></inline-formula> estimates the deviation from the population slope for subject i and are assumed independent and Gaussian with mean 0 and variance <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e010" xlink:type="simple"/></inline-formula>.</p>
<p><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e011" xlink:type="simple"/></inline-formula> represents the random deviation of the j<sup>th</sup> measurement for the i<sup>th</sup> subject and are assumed independent and Gaussian with mean 0 and variance <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pone.0106631.e012" xlink:type="simple"/></inline-formula>.</p>
<p>Additional covariates included in the models allow for additional variation in the population intercepts. The models were fit using the “lme” function found in the R package “nlme” <xref ref-type="bibr" rid="pone.0106631-Pinheiro1">[17]</xref>–<xref ref-type="bibr" rid="pone.0106631-Laird1">[19]</xref></p>
<p>A Wald test of the regression coefficient for the interaction term between visit and SNP was used to test whether the rates of change in the measurement over time differed according to the number of risk alleles. Since some mixed models did not converge when baseline uACR was included as a covariate, the fully adjusted models were evaluated using a two-stage linear regression procedure. In the first stage, a linear regression model regressing the measurement as a function of the visit (0, 2 or 5 years) was performed for each patient separately resulting in an estimated slope (rate of change in the measurement per year) for each patient. In the second stage, we used regression models to estimate the effect per risk allele on patient specific slopes. In models that assessed the rate of change in albuminuria, patients with baseline uACR ≥100 mg/g (n = 401) were excluded because this analysis was focused on worsening albuminuria among patients that do not already have substantially elevated levels of urine albumin. Using a similar rationale, models that assessed the rate of eGFR change, patients with baseline eGFR &lt;60 ml/min/1.73 m<sup>2</sup> were excluded (n = 960). Incident albuminuria was defined as uACR&gt;30 mg/g in years 2 and 5, year 5 only, or year 2 when year 5 data was missing.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<p>This substudy of ONTARGET and TRANSCEND included 3128 patients from ONTARGET and 595 patients from TRANSCEND. These patients were mostly male patients (<xref ref-type="table" rid="pone-0106631-t001">Table 1</xref>) with either prevalent (n = 2920) or incident (n = 803) diabetes. Most of the patients (75%) in this substudy were self-described Europeans. The baseline characteristics of the patients who were included in this genetic substudy of diabetic patients from ONTARGET and TRANSCEND were in general similar to the baseline characteristics of all diabetic patients in ONTARGET and TRANSCEND (<xref ref-type="table" rid="pone-0106631-t001">Table 1</xref>). However, the fraction of patients in the European, Asian, and Native Latin self- reported ethnicities was different in study participants compared with all diabetics in ONTARGET and TRANSCEND, likely reflecting the low availability of DNA from patients recruited in Asia and Latin America.</p>
<p>In this substudy, we investigated 16 SNPs that were previously reported to be associated with eGFR in cross-sectional studies (<xref ref-type="table" rid="pone-0106631-t002">Table 2</xref>). First we investigated the association of these SNPs with annual rate of increase in albuminuria among those with European ancestry and among all ethnic groups (<xref ref-type="table" rid="pone-0106631-t003">Table 3</xref>). We found that 1 of the 16 SNPs (rs267734 in CERS2) was associated with differential annual rate of increase in albuminuria after accounting for testing 16 SNPs (P = 0.0015, Bonferroni corrected P value for α = 0.05 of 16 tests is 0.0032) and after adjustment for age, sex, ethnicity, and principal components of genetic variability. The median annual rate of increase in albuminuria in this population, regardless of genotype, was 6.8% (IQR 2.1% to 12.9%). However, among carriers of 2 risk alleles of this SNP, albuminuria increased at an annual rate of 11.3% (95%CI, 7.5% to 15.3%), compared with an annual rate of 5.0% (95%CI; 3.3% to 6.8%) for carriers of one risk allele (heterozygotes), and 1.7% (95%CI, −1.7% to 5.3%) for carriers of no risk alleles (<xref ref-type="fig" rid="pone-0106631-g001">Figure 1</xref>). Further adjusting this association for baseline hypertension, eGFR, uACR, smoking, study (ONTARGET or TRANSCEND), and treatment group did not appreciably change the association of rs267734 with rate of increase in albuminuria (P = 0.0034). Among patients who were normo-albuminuric at baseline (uACR&lt;30 mg/g), each risk allele was associated with 50% increased risk of incident albuminuria (OR = 1.50; 95%CI 1.15 to 1.95; P = 0.003) after adjusting for age, sex, ethnicity, principal components of genetic variability, baseline hypertension, eGFR, uACR, smoking, study (ONTARGET or TRANSCEND), and treatment group.</p>
<fig id="pone-0106631-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106631.g001</object-id><label>Figure 1</label><caption>
<title>Whiskers denote 95% confidence intervals derived from linear mixed models adjusted for age, sex, and principal components of genetic variation.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0106631.g001" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0106631-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106631.t002</object-id><label>Table 2</label><caption>
<title>SNPs associated with eGFR in cross-sectional studies.</title>
</caption><alternatives><graphic id="pone-0106631-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0106631.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">SNP</td>
<td align="left" rowspan="1" colspan="1">Lead SNP</td>
<td align="left" rowspan="1" colspan="1">LD (r<sup>2</sup>)</td>
<td align="left" rowspan="1" colspan="1">Alleles (Risk/Non-risk)</td>
<td align="left" rowspan="1" colspan="1">Allele Frequency (Risk)</td>
<td align="left" rowspan="1" colspan="1">Locus</td>
<td align="left" rowspan="1" colspan="1">Genes</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">rs267734</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/G</td>
<td align="left" rowspan="1" colspan="1">0.79</td>
<td align="left" rowspan="1" colspan="1">1q21.3</td>
<td align="left" rowspan="1" colspan="1">CERS2, ANXA9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1260326</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">G/A</td>
<td align="left" rowspan="1" colspan="1">0.59</td>
<td align="left" rowspan="1" colspan="1">2p23.3</td>
<td align="left" rowspan="1" colspan="1">GCKR</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs13538</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/G</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
<td align="left" rowspan="1" colspan="1">2p13.1</td>
<td align="left" rowspan="1" colspan="1">NAT8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs347685</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/C</td>
<td align="left" rowspan="1" colspan="1">0.73</td>
<td align="left" rowspan="1" colspan="1">3q23</td>
<td align="left" rowspan="1" colspan="1">TFDP2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17319721</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/G</td>
<td align="left" rowspan="1" colspan="1">0.42</td>
<td align="left" rowspan="1" colspan="1">4q21.1</td>
<td align="left" rowspan="1" colspan="1">SHROOM3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs11959928</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/T</td>
<td align="left" rowspan="1" colspan="1">0.45</td>
<td align="left" rowspan="1" colspan="1">5p13.1</td>
<td align="left" rowspan="1" colspan="1">DAB2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs6420094</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">C/T</td>
<td align="left" rowspan="1" colspan="1">0.33</td>
<td align="left" rowspan="1" colspan="1">5q35.3</td>
<td align="left" rowspan="1" colspan="1">SLC34A1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs881858</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/G</td>
<td align="left" rowspan="1" colspan="1">0.70</td>
<td align="left" rowspan="1" colspan="1">6p21.1</td>
<td align="left" rowspan="1" colspan="1">VEGFA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs7805747</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/G</td>
<td align="left" rowspan="1" colspan="1">0.28</td>
<td align="left" rowspan="1" colspan="1">7q36.1</td>
<td align="left" rowspan="1" colspan="1">PRKAG2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17786744</td>
<td align="left" rowspan="1" colspan="1">rs10109414</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">G/A</td>
<td align="left" rowspan="1" colspan="1">0.42</td>
<td align="left" rowspan="1" colspan="1">8p21.2</td>
<td align="left" rowspan="1" colspan="1">STC1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4744712</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/C</td>
<td align="left" rowspan="1" colspan="1">0.39</td>
<td align="left" rowspan="1" colspan="1">9q21.11</td>
<td align="left" rowspan="1" colspan="1">PIP5K1B</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs653178</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">G/A</td>
<td align="left" rowspan="1" colspan="1">0.50</td>
<td align="left" rowspan="1" colspan="1">12q24.12</td>
<td align="left" rowspan="1" colspan="1">ATXN2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs626277</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/C</td>
<td align="left" rowspan="1" colspan="1">0.61</td>
<td align="left" rowspan="1" colspan="1">13q21.33</td>
<td align="left" rowspan="1" colspan="1">DACH1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1394125</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">A/G</td>
<td align="left" rowspan="1" colspan="1">0.35</td>
<td align="left" rowspan="1" colspan="1">15q24.2</td>
<td align="left" rowspan="1" colspan="1">UBE2Q2</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4293393</td>
<td align="left" rowspan="1" colspan="1">rs12917707</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">A/G</td>
<td align="left" rowspan="1" colspan="1">0.82</td>
<td align="left" rowspan="1" colspan="1">16p12.3</td>
<td align="left" rowspan="1" colspan="1">UMOD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs12460876</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">T/C</td>
<td align="left" rowspan="1" colspan="1">0.61</td>
<td align="left" rowspan="1" colspan="1">19q13.11</td>
<td align="left" rowspan="1" colspan="1">SLC7A9</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p>LD, linkage disequilibrium.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0106631-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106631.t003</object-id><label>Table 3</label><caption>
<title>Association between SNPs and change in albuminuria.</title>
</caption><alternatives><graphic id="pone-0106631-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0106631.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="4" align="left" rowspan="1">Europeans</td>
<td colspan="4" align="left" rowspan="1">All Ethnic Groups</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SNP</td>
<td colspan="3" align="left" rowspan="1">Annual change (%) per number of risk alleles</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Annual change (%) per number of risk alleles</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">P value</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">P value</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">rs267734</td>
<td align="left" rowspan="1" colspan="1">1.99</td>
<td align="left" rowspan="1" colspan="1">4.99</td>
<td align="left" rowspan="1" colspan="1">8.07</td>
<td align="left" rowspan="1" colspan="1">0.0067</td>
<td align="left" rowspan="1" colspan="1">1.75</td>
<td align="left" rowspan="1" colspan="1">5.03</td>
<td align="left" rowspan="1" colspan="1">11.33</td>
<td align="left" rowspan="1" colspan="1">0.0015</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1260326</td>
<td align="left" rowspan="1" colspan="1">8.61</td>
<td align="left" rowspan="1" colspan="1">7.07</td>
<td align="left" rowspan="1" colspan="1">5.56</td>
<td align="left" rowspan="1" colspan="1">0.11</td>
<td align="left" rowspan="1" colspan="1">8.14</td>
<td align="left" rowspan="1" colspan="1">9.04</td>
<td align="left" rowspan="1" colspan="1">11.68</td>
<td align="left" rowspan="1" colspan="1">0.44</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs13538</td>
<td align="left" rowspan="1" colspan="1">5.56</td>
<td align="left" rowspan="1" colspan="1">6.34</td>
<td align="left" rowspan="1" colspan="1">7.13</td>
<td align="left" rowspan="1" colspan="1">0.50</td>
<td align="left" rowspan="1" colspan="1">6.04</td>
<td align="left" rowspan="1" colspan="1">9.18</td>
<td align="left" rowspan="1" colspan="1">11.44</td>
<td align="left" rowspan="1" colspan="1">0.40</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs347685</td>
<td align="left" rowspan="1" colspan="1">5.23</td>
<td align="left" rowspan="1" colspan="1">6.31</td>
<td align="left" rowspan="1" colspan="1">7.41</td>
<td align="left" rowspan="1" colspan="1">0.31</td>
<td align="left" rowspan="1" colspan="1">9.00</td>
<td align="left" rowspan="1" colspan="1">10.28</td>
<td align="left" rowspan="1" colspan="1">9.97</td>
<td align="left" rowspan="1" colspan="1">0.45</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17319721</td>
<td align="left" rowspan="1" colspan="1">6.73</td>
<td align="left" rowspan="1" colspan="1">6.77</td>
<td align="left" rowspan="1" colspan="1">6.80</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">11.27</td>
<td align="left" rowspan="1" colspan="1">7.05</td>
<td align="left" rowspan="1" colspan="1">6.72</td>
<td align="left" rowspan="1" colspan="1">0.63</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs11959928</td>
<td align="left" rowspan="1" colspan="1">6.20</td>
<td align="left" rowspan="1" colspan="1">6.85</td>
<td align="left" rowspan="1" colspan="1">7.51</td>
<td align="left" rowspan="1" colspan="1">0.50</td>
<td align="left" rowspan="1" colspan="1">10.25</td>
<td align="left" rowspan="1" colspan="1">9.93</td>
<td align="left" rowspan="1" colspan="1">8.01</td>
<td align="left" rowspan="1" colspan="1">0.57</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs6420094</td>
<td align="left" rowspan="1" colspan="1">5.92</td>
<td align="left" rowspan="1" colspan="1">7.24</td>
<td align="left" rowspan="1" colspan="1">8.58</td>
<td align="left" rowspan="1" colspan="1">0.20</td>
<td align="left" rowspan="1" colspan="1">9.28</td>
<td align="left" rowspan="1" colspan="1">11.05</td>
<td align="left" rowspan="1" colspan="1">10.53</td>
<td align="left" rowspan="1" colspan="1">0.15</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs881858</td>
<td align="left" rowspan="1" colspan="1">8.32</td>
<td align="left" rowspan="1" colspan="1">7.22</td>
<td align="left" rowspan="1" colspan="1">6.14</td>
<td align="left" rowspan="1" colspan="1">0.30</td>
<td align="left" rowspan="1" colspan="1">13.33</td>
<td align="left" rowspan="1" colspan="1">11.21</td>
<td align="left" rowspan="1" colspan="1">8.33</td>
<td align="left" rowspan="1" colspan="1">0.086</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs7805747</td>
<td align="left" rowspan="1" colspan="1">6.41</td>
<td align="left" rowspan="1" colspan="1">7.07</td>
<td align="left" rowspan="1" colspan="1">7.74</td>
<td align="left" rowspan="1" colspan="1">0.52</td>
<td align="left" rowspan="1" colspan="1">10.74</td>
<td align="left" rowspan="1" colspan="1">7.35</td>
<td align="left" rowspan="1" colspan="1">7.69</td>
<td align="left" rowspan="1" colspan="1">0.89</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17786744</td>
<td align="left" rowspan="1" colspan="1">5.81</td>
<td align="left" rowspan="1" colspan="1">6.94</td>
<td align="left" rowspan="1" colspan="1">8.09</td>
<td align="left" rowspan="1" colspan="1">0.23</td>
<td align="left" rowspan="1" colspan="1">9.46</td>
<td align="left" rowspan="1" colspan="1">10.38</td>
<td align="left" rowspan="1" colspan="1">8.81</td>
<td align="left" rowspan="1" colspan="1">0.23</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4744712</td>
<td align="left" rowspan="1" colspan="1">6.50</td>
<td align="left" rowspan="1" colspan="1">6.85</td>
<td align="left" rowspan="1" colspan="1">7.20</td>
<td align="left" rowspan="1" colspan="1">0.72</td>
<td align="left" rowspan="1" colspan="1">8.80</td>
<td align="left" rowspan="1" colspan="1">11.15</td>
<td align="left" rowspan="1" colspan="1">12.27</td>
<td align="left" rowspan="1" colspan="1">0.42</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs653178</td>
<td align="left" rowspan="1" colspan="1">7.35</td>
<td align="left" rowspan="1" colspan="1">6.77</td>
<td align="left" rowspan="1" colspan="1">6.20</td>
<td align="left" rowspan="1" colspan="1">0.54</td>
<td align="left" rowspan="1" colspan="1">10.45</td>
<td align="left" rowspan="1" colspan="1">7.68</td>
<td align="left" rowspan="1" colspan="1">6.45</td>
<td align="left" rowspan="1" colspan="1">0.49</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs626277</td>
<td align="left" rowspan="1" colspan="1">8.38</td>
<td align="left" rowspan="1" colspan="1">7.07</td>
<td align="left" rowspan="1" colspan="1">5.78</td>
<td align="left" rowspan="1" colspan="1">0.18</td>
<td align="left" rowspan="1" colspan="1">10.33</td>
<td align="left" rowspan="1" colspan="1">8.65</td>
<td align="left" rowspan="1" colspan="1">8.96</td>
<td align="left" rowspan="1" colspan="1">0.75</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1394125</td>
<td align="left" rowspan="1" colspan="1">6.06</td>
<td align="left" rowspan="1" colspan="1">7.08</td>
<td align="left" rowspan="1" colspan="1">8.12</td>
<td align="left" rowspan="1" colspan="1">0.30</td>
<td align="left" rowspan="1" colspan="1">10.83</td>
<td align="left" rowspan="1" colspan="1">9.01</td>
<td align="left" rowspan="1" colspan="1">8.22</td>
<td align="left" rowspan="1" colspan="1">0.54</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4293393</td>
<td align="left" rowspan="1" colspan="1">4.81</td>
<td align="left" rowspan="1" colspan="1">6.00</td>
<td align="left" rowspan="1" colspan="1">7.21</td>
<td align="left" rowspan="1" colspan="1">0.33</td>
<td align="left" rowspan="1" colspan="1">6.05</td>
<td align="left" rowspan="1" colspan="1">9.06</td>
<td align="left" rowspan="1" colspan="1">10.19</td>
<td align="left" rowspan="1" colspan="1">0.37</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs12460876</td>
<td align="left" rowspan="1" colspan="1">5.58</td>
<td align="left" rowspan="1" colspan="1">6.57</td>
<td align="left" rowspan="1" colspan="1">7.58</td>
<td align="left" rowspan="1" colspan="1">0.30</td>
<td align="left" rowspan="1" colspan="1">9.64</td>
<td align="left" rowspan="1" colspan="1">9.96</td>
<td align="left" rowspan="1" colspan="1">8.95</td>
<td align="left" rowspan="1" colspan="1">0.40</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p>Results were adjusted for age, sex, 10 largest principal components of genetic variation and self-reported ethnicity (for “all ethnic groups” results).</p></fn></table-wrap-foot></table-wrap>
<p>We investigated whether other SNPs in the rs267734 locus were also associated with annual rate of increase in albuminuria (<xref ref-type="fig" rid="pone-0106631-g002">Figure 2</xref>). An investigation of 144 SNPs in this locus in the combined ethnic groups found that 19 of these SNPs were nominally associated with annual rate of increase in albuminuria (P&lt;0.05, <xref ref-type="supplementary-material" rid="pone.0106631.s001">Table S1</xref>). However, after adjusting the associations for the original CERS2 SNP (rs267734) only 3 SNPs remained associated with albuminuria progression (rs3811402, P = 0.0024; rs61751619, P = 0.036; and rs76098726, P = 0.019). These 3 SNPs were in low linkage disequilibrium with the original CERS2 SNP (r<sup>2</sup>&lt;0.02 in Europeans). Of the 19 SNPs that were associated with annual rate of increase prior to adjusting for rs267734, only one SNP in this locus (rs267738) had an association P value smaller than rs267734 (P = 0.0013). This SNP (rs267738) encodes a glutamic acid to alanine change at position 115 of the protein encoded by CERS2. These two SNPs in CERS2 (rs267734 and rs267738) are highly correlated (linkage disequilibrium r<sup>2</sup> = 0.94) in those with European ancestry in this substudy.</p>
<fig id="pone-0106631-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106631.g002</object-id><label>Figure 2</label><caption>
<title>Regional plot for the CERS2 locus.</title>
<p>SNPs are plotted by association P value of linear mixed models adjusted for age, sex, and principal components of genetic variation for the association between SNP and annual rate of change in albuminuria. and genomic position (NCBI Build 36). The original hit (rs267734) is labeled. The magnitude of linkage disequilibrium (r<sup>2</sup>) between each SNP and rs267734 is indicated by the intensity of the red coloring. Estimates of recombination rates are shown by the blue line. Gene positions are indicated by green arrows. Gene names are labeled. Linkage disequilibrium and recombination rates were estimated from the Utah residents of Northern and Western European ancestry (CEU) HapMap population (release 22). Plots were prepared using SNAP <xref ref-type="bibr" rid="pone.0106631-Laviad1">[22]</xref>. Panel A: P values adjusted for rs267734. Panel B: P values not adjusted for rs267734.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0106631.g002" position="float" xlink:type="simple"/></fig>
<p>We also investigated the association of these 16 SNPs with baseline albuminuria levels (<xref ref-type="table" rid="pone-0106631-t004">Table 4</xref>) and found that one SNP (rs13538 in NAT8) was associated with albuminuria in a combined analysis of all ethnic groups (P = 0.009), although this association did not reach statistical significance when Bonferroni correction was applied to adjust for testing 16 SNPs. Paradoxically, the rs13538 allele that was reported to be associated with low eGFR was found to be associated with low baseline albuminuria in our study.</p>
<table-wrap id="pone-0106631-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106631.t004</object-id><label>Table 4</label><caption>
<title>Association between SNPs and baseline albuminuria.</title>
</caption><alternatives><graphic id="pone-0106631-t004-4" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0106631.t004" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">Europeans</td>
<td colspan="2" align="left" rowspan="1">All Ethnic Groups</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SNP</td>
<td align="left" rowspan="1" colspan="1">β</td>
<td align="left" rowspan="1" colspan="1">P value</td>
<td align="left" rowspan="1" colspan="1">β</td>
<td align="left" rowspan="1" colspan="1">P value</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">rs267734</td>
<td align="left" rowspan="1" colspan="1">0.0043</td>
<td align="left" rowspan="1" colspan="1">0.94</td>
<td align="left" rowspan="1" colspan="1">0.015</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1260326</td>
<td align="left" rowspan="1" colspan="1">−0.0439</td>
<td align="left" rowspan="1" colspan="1">0.34</td>
<td align="left" rowspan="1" colspan="1">−0.0381</td>
<td align="left" rowspan="1" colspan="1">0.36</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs13538</td>
<td align="left" rowspan="1" colspan="1">−0.1048</td>
<td align="left" rowspan="1" colspan="1">0.057</td>
<td align="left" rowspan="1" colspan="1">−0.1337</td>
<td align="left" rowspan="1" colspan="1">0.009</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs347685</td>
<td align="left" rowspan="1" colspan="1">0.0293</td>
<td align="left" rowspan="1" colspan="1">0.57</td>
<td align="left" rowspan="1" colspan="1">0.0175</td>
<td align="left" rowspan="1" colspan="1">0.71</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17319721</td>
<td align="left" rowspan="1" colspan="1">−0.0096</td>
<td align="left" rowspan="1" colspan="1">0.84</td>
<td align="left" rowspan="1" colspan="1">−0.0684</td>
<td align="left" rowspan="1" colspan="1">0.51</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs11959928</td>
<td align="left" rowspan="1" colspan="1">0.0183</td>
<td align="left" rowspan="1" colspan="1">0.69</td>
<td align="left" rowspan="1" colspan="1">0.0111</td>
<td align="left" rowspan="1" colspan="1">0.79</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs6420094</td>
<td align="left" rowspan="1" colspan="1">0.0131</td>
<td align="left" rowspan="1" colspan="1">0.79</td>
<td align="left" rowspan="1" colspan="1">0.018</td>
<td align="left" rowspan="1" colspan="1">0.69</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs881858</td>
<td align="left" rowspan="1" colspan="1">−0.0449</td>
<td align="left" rowspan="1" colspan="1">0.36</td>
<td align="left" rowspan="1" colspan="1">−0.0598</td>
<td align="left" rowspan="1" colspan="1">0.18</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs7805747</td>
<td align="left" rowspan="1" colspan="1">−0.0651</td>
<td align="left" rowspan="1" colspan="1">0.19</td>
<td align="left" rowspan="1" colspan="1">−0.0664</td>
<td align="left" rowspan="1" colspan="1">0.16</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17786744</td>
<td align="left" rowspan="1" colspan="1">−0.0600</td>
<td align="left" rowspan="1" colspan="1">0.18</td>
<td align="left" rowspan="1" colspan="1">−0.0258</td>
<td align="left" rowspan="1" colspan="1">0.74</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4744712</td>
<td align="left" rowspan="1" colspan="1">−0.0462</td>
<td align="left" rowspan="1" colspan="1">0.32</td>
<td align="left" rowspan="1" colspan="1">−0.066</td>
<td align="left" rowspan="1" colspan="1">0.12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs653178</td>
<td align="left" rowspan="1" colspan="1">0.0152</td>
<td align="left" rowspan="1" colspan="1">0.74</td>
<td align="left" rowspan="1" colspan="1">−0.0019</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs626277</td>
<td align="left" rowspan="1" colspan="1">−0.0069</td>
<td align="left" rowspan="1" colspan="1">0.88</td>
<td align="left" rowspan="1" colspan="1">−0.0009</td>
<td align="left" rowspan="1" colspan="1">0.98</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1394125</td>
<td align="left" rowspan="1" colspan="1">−0.0090</td>
<td align="left" rowspan="1" colspan="1">0.85</td>
<td align="left" rowspan="1" colspan="1">0.0072</td>
<td align="left" rowspan="1" colspan="1">0.87</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4293393</td>
<td align="left" rowspan="1" colspan="1">−0.0612</td>
<td align="left" rowspan="1" colspan="1">0.30</td>
<td align="left" rowspan="1" colspan="1">−0.0623</td>
<td align="left" rowspan="1" colspan="1">0.25</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs12460876</td>
<td align="left" rowspan="1" colspan="1">0.0021</td>
<td align="left" rowspan="1" colspan="1">0.96</td>
<td align="left" rowspan="1" colspan="1">0.0045</td>
<td align="left" rowspan="1" colspan="1">0.93</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt104"><label/><p>β is the expected change in log-transformed baseline albuminuria for each risk allele. Models are adjusted for age, sex, 10 largest principal components of genetic variation, and self-reported ethnicity.</p></fn></table-wrap-foot></table-wrap>
<p>Finally, we sought to confirm the previously reported association of these 16 SNPs with baseline eGFR in this study. Among patients with self-described European ancestry—the largest ethnic group in this substudy—we found that 3 of the 16 SNPs (rs267734 in CERS2, rs347685 in TFDP2, and rs653178 in ATXN2) were associated with baseline eGFR (P≤0.05, <xref ref-type="table" rid="pone-0106631-t005">Table 5</xref>). As expected, patients carrying the pre-specified risk alleles of 13 of the 16 SNPs had lower eGFR than non-carriers. A combined analysis of all ethnic groups found that only one SNP (rs347685 in TFDP2) was associated with eGFR (P = 0.049) and that carriers of the risk alleles of 10 of the 16 SNPs had lower eGFR than non-carriers. None of the SNPs were associated with annual rate of eGFR change among either Europeans or in a combined analysis of all ethnic groups (<xref ref-type="table" rid="pone-0106631-t006">Table 6</xref>).</p>
<table-wrap id="pone-0106631-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106631.t005</object-id><label>Table 5</label><caption>
<title>Association between SNPs and baseline eGFR.</title>
</caption><alternatives><graphic id="pone-0106631-t005-5" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0106631.t005" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">Europeans</td>
<td colspan="2" align="left" rowspan="1">All Ethnic Groups</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SNP</td>
<td align="left" rowspan="1" colspan="1">β</td>
<td align="left" rowspan="1" colspan="1">P value</td>
<td align="left" rowspan="1" colspan="1">β</td>
<td align="left" rowspan="1" colspan="1">P value</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">rs267734</td>
<td align="left" rowspan="1" colspan="1">−0.0269</td>
<td align="left" rowspan="1" colspan="1">0.002</td>
<td align="left" rowspan="1" colspan="1">0.0038</td>
<td align="left" rowspan="1" colspan="1">0.89</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1260326</td>
<td align="left" rowspan="1" colspan="1">−0.0087</td>
<td align="left" rowspan="1" colspan="1">0.23</td>
<td align="left" rowspan="1" colspan="1">−0.0195</td>
<td align="left" rowspan="1" colspan="1">0.33</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs13538</td>
<td align="left" rowspan="1" colspan="1">−0.004</td>
<td align="left" rowspan="1" colspan="1">0.65</td>
<td align="left" rowspan="1" colspan="1">0.0178</td>
<td align="left" rowspan="1" colspan="1">0.34</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs347685</td>
<td align="left" rowspan="1" colspan="1">−0.016</td>
<td align="left" rowspan="1" colspan="1">0.05</td>
<td align="left" rowspan="1" colspan="1">−0.0147</td>
<td align="left" rowspan="1" colspan="1">0.049</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17319721</td>
<td align="left" rowspan="1" colspan="1">0.006</td>
<td align="left" rowspan="1" colspan="1">0.41</td>
<td align="left" rowspan="1" colspan="1">0.013</td>
<td align="left" rowspan="1" colspan="1">0.39</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs11959928</td>
<td align="left" rowspan="1" colspan="1">−0.0097</td>
<td align="left" rowspan="1" colspan="1">0.18</td>
<td align="left" rowspan="1" colspan="1">−0.0088</td>
<td align="left" rowspan="1" colspan="1">0.30</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs6420094</td>
<td align="left" rowspan="1" colspan="1">−0.0048</td>
<td align="left" rowspan="1" colspan="1">0.53</td>
<td align="left" rowspan="1" colspan="1">−0.0434</td>
<td align="left" rowspan="1" colspan="1">0.064</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs881858</td>
<td align="left" rowspan="1" colspan="1">−0.0147</td>
<td align="left" rowspan="1" colspan="1">0.062</td>
<td align="left" rowspan="1" colspan="1">0.0164</td>
<td align="left" rowspan="1" colspan="1">0.44</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs7805747</td>
<td align="left" rowspan="1" colspan="1">−0.013</td>
<td align="left" rowspan="1" colspan="1">0.10</td>
<td align="left" rowspan="1" colspan="1">−0.0098</td>
<td align="left" rowspan="1" colspan="1">0.19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17786744</td>
<td align="left" rowspan="1" colspan="1">−0.009</td>
<td align="left" rowspan="1" colspan="1">0.21</td>
<td align="left" rowspan="1" colspan="1">−0.0099</td>
<td align="left" rowspan="1" colspan="1">0.13</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4744712</td>
<td align="left" rowspan="1" colspan="1">−0.0065</td>
<td align="left" rowspan="1" colspan="1">0.38</td>
<td align="left" rowspan="1" colspan="1">−0.0062</td>
<td align="left" rowspan="1" colspan="1">0.35</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs653178</td>
<td align="left" rowspan="1" colspan="1">−0.0144</td>
<td align="left" rowspan="1" colspan="1">0.046</td>
<td align="left" rowspan="1" colspan="1">−0.013</td>
<td align="left" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs626277</td>
<td align="left" rowspan="1" colspan="1">0.0051</td>
<td align="left" rowspan="1" colspan="1">0.49</td>
<td align="left" rowspan="1" colspan="1">0.0044</td>
<td align="left" rowspan="1" colspan="1">0.52</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1394125</td>
<td align="left" rowspan="1" colspan="1">−0.0056</td>
<td align="left" rowspan="1" colspan="1">0.45</td>
<td align="left" rowspan="1" colspan="1">−0.0063</td>
<td align="left" rowspan="1" colspan="1">0.36</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4293393</td>
<td align="left" rowspan="1" colspan="1">−0.0175</td>
<td align="left" rowspan="1" colspan="1">0.063</td>
<td align="left" rowspan="1" colspan="1">−0.0172</td>
<td align="left" rowspan="1" colspan="1">0.047</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs12460876</td>
<td align="left" rowspan="1" colspan="1">0.0045</td>
<td align="left" rowspan="1" colspan="1">0.54</td>
<td align="left" rowspan="1" colspan="1">0.0028</td>
<td align="left" rowspan="1" colspan="1">0.67</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt105"><label/><p>β is the expected change in log-transformed baseline eGFR for each risk allele. Models are adjusted for age, sex, 10 largest principal components of genetic variation, and self-reported ethnicity.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0106631-t006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106631.t006</object-id><label>Table 6</label><caption>
<title>Association between SNPs and change in eGFR</title>
</caption><alternatives><graphic id="pone-0106631-t006-6" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0106631.t006" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="4" align="left" rowspan="1">Europeans</td>
<td colspan="4" align="left" rowspan="1">All Ethnic Groups<xref ref-type="table-fn" rid="nt107">*</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SNP</td>
<td colspan="3" align="left" rowspan="1">Annual change (%) by number of risk alleles</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Annual change (%) by number of risk alleles</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">P value</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">P value</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">rs267734</td>
<td align="left" rowspan="1" colspan="1">−2.53</td>
<td align="left" rowspan="1" colspan="1">−2.45</td>
<td align="left" rowspan="1" colspan="1">−2.38</td>
<td align="left" rowspan="1" colspan="1">0.70</td>
<td align="left" rowspan="1" colspan="1">−2.52</td>
<td align="left" rowspan="1" colspan="1">−2.45</td>
<td align="left" rowspan="1" colspan="1">−2.69</td>
<td align="left" rowspan="1" colspan="1">0.75</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1260326</td>
<td align="left" rowspan="1" colspan="1">−2.37</td>
<td align="left" rowspan="1" colspan="1">−2.40</td>
<td align="left" rowspan="1" colspan="1">−2.44</td>
<td align="left" rowspan="1" colspan="1">0.83</td>
<td align="left" rowspan="1" colspan="1">−2.44</td>
<td align="left" rowspan="1" colspan="1">−2.73</td>
<td align="left" rowspan="1" colspan="1">−2.59</td>
<td align="left" rowspan="1" colspan="1">0.82</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs13538</td>
<td align="left" rowspan="1" colspan="1">−2.54</td>
<td align="left" rowspan="1" colspan="1">−2.46</td>
<td align="left" rowspan="1" colspan="1">−2.38</td>
<td align="left" rowspan="1" colspan="1">0.72</td>
<td align="left" rowspan="1" colspan="1">−2.52</td>
<td align="left" rowspan="1" colspan="1">−2.48</td>
<td align="left" rowspan="1" colspan="1">−2.70</td>
<td align="left" rowspan="1" colspan="1">0.80</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs347685</td>
<td align="left" rowspan="1" colspan="1">−2.25</td>
<td align="left" rowspan="1" colspan="1">−2.37</td>
<td align="left" rowspan="1" colspan="1">−2.49</td>
<td align="left" rowspan="1" colspan="1">0.54</td>
<td align="left" rowspan="1" colspan="1">−2.36</td>
<td align="left" rowspan="1" colspan="1">−2.56</td>
<td align="left" rowspan="1" colspan="1">−2.63</td>
<td align="left" rowspan="1" colspan="1">0.48</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17319721</td>
<td align="left" rowspan="1" colspan="1">−2.23</td>
<td align="left" rowspan="1" colspan="1">−2.45</td>
<td align="left" rowspan="1" colspan="1">−2.66</td>
<td align="left" rowspan="1" colspan="1">0.22</td>
<td align="left" rowspan="1" colspan="1">−2.62</td>
<td align="left" rowspan="1" colspan="1">−2.46</td>
<td align="left" rowspan="1" colspan="1">−2.67</td>
<td align="left" rowspan="1" colspan="1">0.22</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs11959928</td>
<td align="left" rowspan="1" colspan="1">−2.47</td>
<td align="left" rowspan="1" colspan="1">−2.41</td>
<td align="left" rowspan="1" colspan="1">−2.35</td>
<td align="left" rowspan="1" colspan="1">0.71</td>
<td align="left" rowspan="1" colspan="1">−2.48</td>
<td align="left" rowspan="1" colspan="1">−3.02</td>
<td align="left" rowspan="1" colspan="1">−3.66</td>
<td align="left" rowspan="1" colspan="1">0.28</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs6420094</td>
<td align="left" rowspan="1" colspan="1">−2.50</td>
<td align="left" rowspan="1" colspan="1">−2.37</td>
<td align="left" rowspan="1" colspan="1">−2.25</td>
<td align="left" rowspan="1" colspan="1">0.50</td>
<td align="left" rowspan="1" colspan="1">−2.76</td>
<td align="left" rowspan="1" colspan="1">−2.4</td>
<td align="left" rowspan="1" colspan="1">−2.26</td>
<td align="left" rowspan="1" colspan="1">0.40</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs881858</td>
<td align="left" rowspan="1" colspan="1">−2.42</td>
<td align="left" rowspan="1" colspan="1">−2.42</td>
<td align="left" rowspan="1" colspan="1">−2.42</td>
<td align="left" rowspan="1" colspan="1">1.00</td>
<td align="left" rowspan="1" colspan="1">−2.44</td>
<td align="left" rowspan="1" colspan="1">−2.46</td>
<td align="left" rowspan="1" colspan="1">−2.74</td>
<td align="left" rowspan="1" colspan="1">0.85</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs7805747</td>
<td align="left" rowspan="1" colspan="1">−2.39</td>
<td align="left" rowspan="1" colspan="1">−2.44</td>
<td align="left" rowspan="1" colspan="1">−2.49</td>
<td align="left" rowspan="1" colspan="1">0.78</td>
<td align="left" rowspan="1" colspan="1">−2.61</td>
<td align="left" rowspan="1" colspan="1">−2.47</td>
<td align="left" rowspan="1" colspan="1">−2.55</td>
<td align="left" rowspan="1" colspan="1">0.66</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs17786744</td>
<td align="left" rowspan="1" colspan="1">−2.41</td>
<td align="left" rowspan="1" colspan="1">−2.42</td>
<td align="left" rowspan="1" colspan="1">−2.42</td>
<td align="left" rowspan="1" colspan="1">0.97</td>
<td align="left" rowspan="1" colspan="1">−2.49</td>
<td align="left" rowspan="1" colspan="1">−2.64</td>
<td align="left" rowspan="1" colspan="1">−2.49</td>
<td align="left" rowspan="1" colspan="1">0.89</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4744712</td>
<td align="left" rowspan="1" colspan="1">−2.40</td>
<td align="left" rowspan="1" colspan="1">−2.41</td>
<td align="left" rowspan="1" colspan="1">−2.43</td>
<td align="left" rowspan="1" colspan="1">0.92</td>
<td align="left" rowspan="1" colspan="1">−3.05</td>
<td align="left" rowspan="1" colspan="1">−2.56</td>
<td align="left" rowspan="1" colspan="1">−2.38</td>
<td align="left" rowspan="1" colspan="1">0.45</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs653178</td>
<td align="left" rowspan="1" colspan="1">−2.50</td>
<td align="left" rowspan="1" colspan="1">−2.41</td>
<td align="left" rowspan="1" colspan="1">−2.32</td>
<td align="left" rowspan="1" colspan="1">0.60</td>
<td align="left" rowspan="1" colspan="1">−2.66</td>
<td align="left" rowspan="1" colspan="1">−2.89</td>
<td align="left" rowspan="1" colspan="1">−2.89</td>
<td align="left" rowspan="1" colspan="1">0.74</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs626277</td>
<td align="left" rowspan="1" colspan="1">−2.63</td>
<td align="left" rowspan="1" colspan="1">−2.45</td>
<td align="left" rowspan="1" colspan="1">−2.28</td>
<td align="left" rowspan="1" colspan="1">0.31</td>
<td align="left" rowspan="1" colspan="1">−2.72</td>
<td align="left" rowspan="1" colspan="1">−2.58</td>
<td align="left" rowspan="1" colspan="1">−2.32</td>
<td align="left" rowspan="1" colspan="1">0.40</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs1394125</td>
<td align="left" rowspan="1" colspan="1">−2.47</td>
<td align="left" rowspan="1" colspan="1">−2.40</td>
<td align="left" rowspan="1" colspan="1">−2.32</td>
<td align="left" rowspan="1" colspan="1">0.68</td>
<td align="left" rowspan="1" colspan="1">−2.74</td>
<td align="left" rowspan="1" colspan="1">−2.41</td>
<td align="left" rowspan="1" colspan="1">−2.33</td>
<td align="left" rowspan="1" colspan="1">0.60</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs4293393</td>
<td align="left" rowspan="1" colspan="1">−2.28</td>
<td align="left" rowspan="1" colspan="1">−2.36</td>
<td align="left" rowspan="1" colspan="1">−2.44</td>
<td align="left" rowspan="1" colspan="1">0.71</td>
<td align="left" rowspan="1" colspan="1">−2.35</td>
<td align="left" rowspan="1" colspan="1">−2.42</td>
<td align="left" rowspan="1" colspan="1">−2.66</td>
<td align="left" rowspan="1" colspan="1">0.73</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">rs12460876</td>
<td align="left" rowspan="1" colspan="1">−2.31</td>
<td align="left" rowspan="1" colspan="1">−2.40</td>
<td align="left" rowspan="1" colspan="1">−2.48</td>
<td align="left" rowspan="1" colspan="1">0.62</td>
<td align="left" rowspan="1" colspan="1">−2.41</td>
<td align="left" rowspan="1" colspan="1">−2.63</td>
<td align="left" rowspan="1" colspan="1">−2.55</td>
<td align="left" rowspan="1" colspan="1">0.51</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt106"><label/><p>Results were adjusted for age, sex, 10 largest principal components of genetic variation and self-reported ethnicity (for “all ethnic groups” results)</p></fn><fn id="nt107"><label/><p>*Mixed regression models did not converge for the self-reported Native Latin group and they were excluded from the analysis.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4">
<title>Discussion</title>
<p>In a pre-specified investigation of 16 SNPs that were previously found to be associated with eGFR we found that one SNP (rs267734) in the CERS2 gene was associated with annual rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND after adjusting for other established risk factors for CKD progression including baseline albuminuria and baseline eGFR. Each risk allele of rs267734 was associated with 50% increased risk of incident albuminuria.</p>
<p>This SNP was not associated with baseline albuminuria in our study. It was also not reported to be associated with baseline albuminuria in large cross sectional analysis of population-based studies <xref ref-type="bibr" rid="pone.0106631-Ellis1">[8]</xref>, <xref ref-type="bibr" rid="pone.0106631-Bger2">[20]</xref>. Thus, this SNP may only be associated with rate of increase in albuminuria in this population of patients with diabetes who were predisposed to a rapid change in albuminuria. The rs267734 SNP was not associated with deterioration of eGFR—another indicator of worsening kidney function. That this SNP is associated with rate of increase in albuminuria and not with rate of deterioration of eGFR may suggest that increase in albuminuria is more rapid, or that increase in albuminuria precedes deterioration of eGFR among patients with diabetes.</p>
<p>CERS2 encodes ceramide synthase 2, one of 6 mammalian ceramide synthases which acylate dihydro-sphingosine to form dihydro-ceramide or sphingosine to form ceramide <xref ref-type="bibr" rid="pone.0106631-Hannun1">[21]</xref>. Ceramides are intra- and extra-cellular signaling molecules that play a role in several pathological and physiological processes including inflammation, diabetes, and angiogenesis <xref ref-type="bibr" rid="pone.0106631-Hannun1">[21]</xref>. CERS2 mRNA has been reported to be the most abundantly expressed ceramide synthase and to be highly expressed in both liver and kidney <xref ref-type="bibr" rid="pone.0106631-Laviad1">[22]</xref>. One study of CERS2 knock-out mice reported morphological changes in the kidney <xref ref-type="bibr" rid="pone.0106631-Imgrund1">[23]</xref>, another study reported normal kidney morphology and function <xref ref-type="bibr" rid="pone.0106631-PewznerJung1">[24]</xref>. The robust expression of CERS2 in mouse kidney could indicate that it might play a role in kidney physiology. However, this role might be obscured by other physiological processes in normal mice. We investigated other SNPs in the CERS2 locus and found another SNP in the CERS2 gene (rs267738) that was as strongly associated with increase in albuminuria as rs267734. These two SNPs are in strong linkage disequilibrium among Europeans; however rs267738 could conceivably be more likely to explain the association because it encodes an amino acid change (glutamic acid to alanine) at position 115 of the CERS2 encoded protein, however, we have no functional data to indicate whether this amino acid change is associated with change in ceramide synthase activity or stability. The more common allele (glutamic acid, 80% frequency among those with European ancestry) is associated with increased rate of change in albuminuria. It would be interesting to investigate the effect of the glutamic acid to alanine substitution at this position on CERS2 activity because it could indicate whether inhibition of ceramide synthase 2 activity would inhibit or promote worsening of albuminuria.</p>
<p>This study has several limitations. Albuminuria was assessed from spot urine at baseline, year 2, and year 5 of follow-up. It is likely that a more accurate assessment of albuminuria and albuminuria progression would be achieved from multiple measurements on consecutive days, and from more frequent longitudinal sampling. We limited the patients in this substudy to those with prevalent or incident diabetes. However, we have no information on the duration of diabetes among those with prevalent diabetes, and thus were unable to adjust the association for potential effects of diabetes duration on albuminuria progression.</p>
<p>In conclusion, we found that a SNP in the CERS2 gene that was previously found to be associated with eGFR was also associated with increase in albuminuria among patients with diabetes and elevated cardiovascular risk. Although this observation has reasonable biological plausibility, it requires replication in additional studies.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0106631.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0106631.s001" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p>Association between SNPs in the CERS2 locus and change in albuminuria.</p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>The authors would like to thank ONTARGET and TRANSCEND investigators and patients. Without their contributions these studies would not have been possible.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0106631-US1"><label>1</label>
<mixed-citation publication-type="other" xlink:type="simple">U.S. Renal Data System (2012) USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2012; Available: <ext-link ext-link-type="uri" xlink:href="http://www.usrds.org/atlas12.aspx" xlink:type="simple">http://www.usrds.org/atlas12.aspx</ext-link>. Accessed: 2014 Jan 10.</mixed-citation>
</ref>
<ref id="pone.0106631-Adler1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adler</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Manley</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Bilous</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Cull</surname><given-names>CA</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)</article-title>. <source>Kidney Int</source> <volume>63</volume>: <fpage>225</fpage>–<lpage>232</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Mann1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mann</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Gerstein</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>QL</given-names></name>, <name name-style="western"><surname>Lonn</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Hoogwerf</surname><given-names>BJ</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study</article-title>. <source>J Am Soc Nephrol</source> <volume>14</volume>: <fpage>641</fpage>–<lpage>647</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Retnakaran1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Retnakaran</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cull</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Thorne</surname><given-names>KI</given-names></name>, <name name-style="western"><surname>Adler</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Holman</surname><given-names>RR</given-names></name> (<year>2006</year>) <article-title>Risk factors for renal dysfunction in type 2 diabetes UK Prospective Diabetes Study 74</article-title>. <source>Diabetes</source> <volume>55</volume>: <fpage>1832</fpage>–<lpage>1839</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Kttgen1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Köttgen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pattaro</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Böger</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Fuchsberger</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Olden</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>New loci associated with kidney function and chronic kidney disease</article-title>. <source>Nat Genet</source> <volume>42</volume>: <fpage>376</fpage>–<lpage>384</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Bger1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Böger</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Gorski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD</article-title>. <source>PLoS Genet</source> <volume>7</volume>: <fpage>e1002292</fpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Deshmukh1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deshmukh</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Colhoun</surname><given-names>HM</given-names></name> (<year>2013</year>) <article-title>Investigation of known estimated glomerular filtration rate loci in patients with Type 2 diabetes</article-title>. <source>Diabet Med</source> <volume>30</volume>: <fpage>1230</fpage>–<lpage>1235</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Ellis1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ellis</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Larson</surname><given-names>MG</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Validated SNPs for eGFR and their associations with albuminuria</article-title>. <source>Hum Mol Genet</source> <volume>21</volume>: <fpage>3293</fpage>–<lpage>3298</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Teo1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Teo</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yusuf</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sleight</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mookadam</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>ONTARGET/TRANSCEND Investigators: Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials</article-title>. <source>Am Heart J</source> <volume>148</volume>: <fpage>52</fpage>–<lpage>61</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Yusuf1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yusuf</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Teo</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pogue</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dyal</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial</article-title>. <source>Lancet</source> <volume>372</volume>: <fpage>1174</fpage>–<lpage>1183</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Yusuf2"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yusuf</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Teo</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Pogue</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dyal</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Copland</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Telmisartan, ramipril, or both in patients at high risk for vascular events</article-title>. <source>N Engl J Med</source> <volume>358</volume>: <fpage>1547</fpage>–<lpage>1559</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Voight1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Voight</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Sidore</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits</article-title>. <source>PLoS Genet</source> <volume>8</volume>: <fpage>e1002793</fpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Fellay1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fellay</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gumbs</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Urban</surname><given-names>TJ</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C</article-title>. <source>Nature</source> <volume>464</volume>: <fpage>405</fpage>–<lpage>408</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Shiffman1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shiffman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Rowland</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Malloy</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Luke</surname><given-names>MM</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Identification of four gene variants associated with myocardial infarction</article-title>. <source>Am J Hum Genet</source> <volume>77</volume>: <fpage>596</fpage>–<lpage>605</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Price1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Price</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Plenge</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Weinblatt</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Shadick</surname><given-names>NA</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Principal components analysis corrects for stratification in genome-wide association studies Nat Genet</article-title>. <volume>38</volume>: <fpage>904</fpage>–<lpage>909</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-DerSimonian1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-Analysis in Clinical Trials Controlled Clinical Trials</article-title>. <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Pinheiro1"><label>17</label>
<mixed-citation publication-type="other" xlink:type="simple">Pinheiro JC, Bates DM, DebRoy S, Sarkar D, R Development Core Team (2012). nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1–103.</mixed-citation>
</ref>
<ref id="pone.0106631-Pinheiro2"><label>18</label>
<mixed-citation publication-type="other" xlink:type="simple">Pinheiro JC, Bates DM (2000) Mixed-Effects Models in S and S-PLUS, New York: Springer-Verlag New York, Inc.</mixed-citation>
</ref>
<ref id="pone.0106631-Laird1"><label>19</label>
<mixed-citation publication-type="other" xlink:type="simple">Laird NM, Ware JH (1982) Random-Effects Models for Longitudinal Data Biometrics, <volume>38</volume>: , 963–974.</mixed-citation>
</ref>
<ref id="pone.0106631-Bger2"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Böger</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Tin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Olden</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Köttgen</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>CUBN is a gene locus for albuminuria</article-title>. <source>J Am Soc Nephrol</source> <volume>22</volume>: <fpage>555</fpage>–<lpage>570</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Hannun1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hannun</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Obeid</surname><given-names>LM</given-names></name> (<year>2011</year>) <article-title>Many ceramides</article-title>. <source>J Biol Chem</source> <volume>286</volume>: <fpage>27855</fpage>–<lpage>27862</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Laviad1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Laviad</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Albee</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pankova-Kholmyansky</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Epstein</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate</article-title>. <source>J Biol Chem</source> <volume>283</volume>: <fpage>5677</fpage>–<lpage>5684</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-Imgrund1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Imgrund</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hartmann</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Farwanah</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Eckhardt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sandhoff</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas</article-title>. <source>J Biol Chem</source> <volume>284</volume>: <fpage>33549</fpage>–<lpage>33560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0106631-PewznerJung1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pewzner-Jung</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Brenner</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Braun</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Laviad</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Ben-Dor</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy</article-title>. <source>J Biol Chem</source> <volume>285</volume>: <fpage>10911</fpage>–<lpage>10923</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>